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Carine H. Cohen
The aim of this study was to quantify the improvements in case ascertainment which are considered to explain
the rise in the incidence of sporadic Creutzfeldt-Jakob disease. The numbers of cases, falling into five 10-year
age groups starting at the age of 30 and three calendar periods of report since 1970, were analyzed by Poisson
regression, assuming a constant age distribution. The age-period and age-cohort models were applied and
discussed. The age-period model showed that underreporting in 1970–1979 was greater among patients aged
70 years or older. The age-cohort model indicated that a cohort factor increased over the first half of the 20th
century (e.g., the incidence in the generation born in 1940 was almost twice that in the generation born in 1920);
this increase was probably an artifact due to the past underascertainment pattern. However, from a statistical
viewpoint, both models lead to a good fit; the cohort factor may appear to be as relevant as the period factor in
describing the trends in incidence. Thus, one can imagine an unlikely worst case scenario, assuming that an
unknown cohort factor is involved. In that case, the age-cohort model gives more optimistic predictions than
Neilson’s model (BMJ 1996;312:1038–9). These results are consistent with both interpretations: The rise in
incidence is governed by improvements in case ascertainment, and is greater among old people (the most
accepted interpretation); this rise may depend on a cohort factor as well, which may correspond to the zoonotic
hypothesis (a totally hypothetical interpretation). Interpreting the increase of sporadic Creutzfeldt-Jakob disease
over generations in terms of exposure to putative environmental factors is still a matter of debate; ongoing
epidemiologic surveys may provide more information. Presently, this increase can be explained as an artifact
due to the past underreporting pattern, with 79% (95% confidence interval: 56, 90) of the cases among persons
aged ≥70 years being missed in 1970–1979. Am J Epidemiol 2000;152:474–9.
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The dramatic increase in sporadic Creutzfeldt-Jakob dis-
ease in the United Kingdom (0.53 cases per million person-
years in 1970–1979, 0.80 in 1980–1989, and 1.18 in
1990–1997) has been attributed to a diagnostic trend result-
ing from improvements in case ascertainment, especially
among older patients (1). However, so far the etiology of
sporadic Creutzfeldt-Jakob disease remains unknown, and
there is concern about the possibility that some unrecog-
nized factors may enhance the risk of developing
Creutzfeldt-Jakob disease (1–4). Indeed, the new variant of
Creutzfeldt-Jakob disease resulted from exposure to the
infectious agent of bovine spongiform encephalopathy
(BSE) (5, 6), and the unknown origin of BSE might be the
infectious agent of scrapie in sheep (7, 8). In the United
Kingdom, a greater than expected incidence of sporadic
Creutzfeldt-Jakob disease has been found among dairy farm
workers and their spouses and among people at increased
risk of contact with BSE-infected cattle (1). An increased
risk has also been found in Europe in relation to consump-
tion of raw meat and brain (2). Because many factors were
studied, these associations were generally considered arti-
facts. Moreover, the power of any study is limited by recall
bias and small numbers of cases: The smallest detectable
relative risk was 4.2 for exposures of 1 percent in van Duijn
et al.’s survey (2). Presently, several epidemiologic inquiries
are ongoing in the European Union to assess putative risk
factors for Creutzfeldt-Jakob disease, including medical his-
tory, occupation, and diet (http://www.cordis.lu). These
studies are investigating the plausible impact of past expo-
sure to prions, particularly scrapie, on the risk of developing
sporadic Creutzfeldt-Jakob disease. They are seeking to
establish whether the rise in incidence may reflect a trend in
past levels of exposure to some unknown environmental
factor(s).
Our purpose in this analysis was not to decide whether
such a link exists. Rather, it was to quantify the consequences
of each plausible interpretation for the rise in sporadic
Creutzfeldt-Jakob disease incidence. In descriptive epidemi-
ology, age-period-cohort models are a useful tool whereby
temporal variations in disease incidence can be presented and
interpreted (9, 10). These models aim to relate incidence
rates to the effects of the individuals’ age, the period of
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observation of those rates, and the generation to which the
subjects belong. The period factor accounts for reporting
trends, and the cohort factor accounts for influences that
affect incidence rates in a specified birth cohort equally
throughout life. We applied an age-period model and an age-
cohort model to the sporadic Creutzfeldt-Jakob disease data
for the United Kingdom from 1970–1997, and we estimated
the period factor due to improvements in case ascertainment,
which is presently considered the explanation for the rise in
sporadic Creutzfeldt-Jakob disease incidence.
MATERIALS AND METHODS
In 1999, the seventh annual report on Creutzfeldt-Jakob
disease surveillance in the United Kingdom was posted on
the World Wide Web (http://www.cjd.ed.ac.uk) by the
National Creutzfeldt-Jakob Disease Surveillance Unit. From
this report, we derived the number of deaths due to sporadic
Creutzfeldt-Jakob disease in England and Wales for the
period 1970–1984 and in the entire United Kingdom for the
period 1985–1997. These numbers were documented by age
group and by period of observation from January 1, 1970,
through December 31, 1997, in agreement with published
data (1). Most of the cases identified (80 percent) were neu-
ropathologically confirmed, and the remainder were clini-
cally probable. Analyses were conducted on 716 cases
falling into five 10-year age groups starting at the age of 30
(one patient aged 14 years was not included) and three cal-
endar periods. The oldest age group consisted of patients
aged 70 years or more (19 cases in 1970–1979 and 110 cases
in 1990–1997).
The numbers of person-years of surveillance, correspond-
ing to the numbers of cases reported, were used to calculate
incidence rates. The population under surveillance was esti-
mated by linear interpolation from census data for 1971,
1981, 1991, and 1996 provided by the UK Office for
National Statistics (see table 1).
Age-period-cohort models assume that the factors’ effects
on the risk of developing sporadic Creutzfeldt-Jakob disease
can be separated. The period factor represents a change
affecting equally and simultaneously the individuals of any
age, typically a modification in reporting rates. The cohort
factor accounts for influences affecting incidence rates in a
specified birth cohort equally throughout life. Cohort effects
do not arise only from etiologic environmental exposures,
nor do period effects necessarily reflect ascertainment; they
could arise from an exposure that had a fixed time span.
However, transmissible spongiform encephalopathies are
characterized by a long and highly variable incubation time.
Therefore, a cohort factor will be described better by an age-
cohort model than by an age-period model (11). Additionally,
the age factor is the physiopathologic effect of age on inci-
dence, stripped of the influences of periods and cohorts.
Assuming that no change occurred in the ages of the cases
across periods or cohorts, the age factor can be estimated
either by an age-period model or by an age-cohort model,
which predicts constant ratios of age-specific rates between
the different periods or cohorts, respectively. A parameter-
ization is chosen so that the parameters look like age-specific
rates for the age factor and have direct interpretations in
terms of relative risks for the period or cohort factor, taking
one period or one cohort as the reference group (9, 10).
The observed numbers of sporadic Creutzfeldt-Jakob dis-
ease cases were assumed to follow a Poisson distribution,
and the log-transformed age-specific incidence rates were
assumed to be a linear function of age group, calendar
period, or cohort effects. Thereby, the cases’ distribution was
analyzed by Poisson regression, fitting two models: the age-
period model, Rij  eK × × , and the age-cohort model,
Rij  e
K × × , where Rij denotes the expected incidence
rate in age group i and calendar period j, K is a constant, Ai
is the effect of age group i (i  1, 2, 3, 4, 5), Pj is the effect
of period j ( j  1, 2, 3), and Ck is the effect of birth cohort k
(k  5 – i  j, k  1, 2, 3, 4, 5, 6, 7). To take into account
the different sizes of the population at different ages i and in
different periods j, we computed incidence rates as the ratio
of the number of cases to the corresponding number of 
person-years of observation, which was set as a constant
(called an “offset”). The binomial distribution (large popula-
tion, low incidence) was approximated by the Poisson distri-
bution. The model’s parameters were estimated by the max-
imum likelihood method, using GLIM software (Numerical
Algorithms Group, Oxford, United Kingdom). As a measure
of the goodness of fit, GLIM gives the deviance, which for
the Poisson distribution is the value of the likelihood ratio
test statistic for the model fitted compared with the saturated
model with a parameter for every observation unit (12). The
models were compared according to the Akaike Information
Criterion, which takes account of the fact that the age-cohort
model has more parameters than the age-period model.
eCkeAi
ePjeAi
TABLE 1. Age distribution of the resident population in England and Wales (censuses of 1971, 1981,
and 1991) and in the United Kingdom (censuses of 1981, 1991, and 1996)*
30–39
40–49
50–59
60–69
≥70
Total
Age
group
(years)
Population in England and Wales (millions)
5,657
6,070
5,873
5,241
4,095
26,936
Population in United Kingdom (millions)
1971 1981 1991
6,900
5,534
5,710
5,097
5,058
28,299
7,120
6,820
5,285
5,029
5,651
29,905
7,771
6,274
6,450
5,736
5,671
31,903
8,067
7,668
5,987
5,676
6,311
33,709
1981 1991 1996
9,132
7,933
6,452
5,418
6,605
35,540
* Data were obtained from the UK Office for National Statistics.
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RESULTS
Tables 1 and 2 give data on the population under surveil-
lance and numbers of cases of sporadic Creutzfeldt-Jakob
disease. Figure 1 displays the observed incidence per 50
million person-years, by age group and period (left side of
the figure) and by age group and cohort (right side of the fig-
ure). Cohorts C1 and C7 corresponded to one observation
unit each and are not represented. There is an increasing
trend, both by period and by cohort, over cohorts C2 to C6.
The models assumed that the curves plotted in the lower half
of the figure were parallels.
A preliminary analysis did not take into account a lower
reporting rate for patients aged ≥70 years in 1970–1979 (1,
13, 14) and led to a significant lack of fit for the age-period
model (8 df; deviance  25.0, p < 0.01). To illustrate the
fact that past underascertainment was more important
among old people (13), we examined an age-period model
in which the number of patients aged ≥70 years in
1970–1979 was estimated by one more parameter, which
allowed the reporting rate in 1970–1979 to be lower for this
age group. This model’s fit was good (7 df; deviance 
13.05, not significant (see table 3)), which confirmed that
case ascertainment (the period factor) was lower in
1970–1979 among people aged ≥70 years.
Table 3 shows that the age-period model, specifying sim-
ilar reporting rates within the different age groups, except
in 1970–1979 for cases aged ≥70 years, led to a good fit (7
df; deviance  13.05, not significant; Akaike Information
Criterion  29.05); and the age-cohort model’s fit was also
satisfactory (4 df; deviance  1.93, not significant; Akaike
Information Criterion  23.93). Table 3 also gives the fac-
tors’ estimates, in terms of relative incidence rate (age
effect) or relative risk (period and cohort effects), taking as
the reference group the fourth age group (60–69 years), the
third period (1990–1997), and the third cohort (1920),
respectively. These levels were used as a reference cate-
gory, since they corresponded to the highest number of
cases observed for each factor. For example, the age-period
model predicted approximately 50 percent fewer cases
(0.45) in the age group 50–59 years than in the age group
60–69 years.
According to the age-period model, by reference to the
period 1990–1997, the estimated reporting rate for
1980–1989 was 0.66 (95 percent confidence interval: 0.56,
0.77); for 1970–1979, it was 0.50 (95 percent confidence
interval: 0.41, 0.62) among cases younger than age 70 and
0.21 (95 percent confidence interval: 0.10, 0.44) among
cases aged ≥70 years. According to the age-cohort model,
there was an increasing trend over the cohorts C2 (1910) to
C6 (1950), whose risks relative to cohort C3 (1920) were
0.60 and 3.27, respectively. However, this trend disappeared
when the data were first corrected for the reporting rates
estimated by the age-period model (by estimating the “true”
number of cases and then fitting the age-cohort model to
these estimated numbers (results not shown)). It clearly indi-
cated that this trend could be interpreted as an artifact due to
the past reporting pattern. However, under the worst case
scenario, in which such a hypothetical trend continued over
the generations born in the second half of the 20th century,
the age-cohort model’s projections led to an increase of less
than 100 additional cases by 2020 (results not shown).
Table 4 gives predictions of the age-period and age-
cohort models, together with the numbers of cases observed,
by age group and by period. The confidence intervals illus-
trate that both models can fit. In this context, it would be
hazardous to draw conclusions on the basis of a statistical
criterion only (14).
DISCUSSION
Our main goal in this analysis was to quantify the improve-
ment in case ascertainment which is thought to account for
the rise in the numbers of sporadic Creutzfeldt-Jakob disease
cases in the United Kingdom. In fact, national surveillance for
Creutzfeldt-Jakob disease was initiated in May 1990 in
response to the recommendation of a working party on BSE
(the Southwood committee). Between 1970 and 1979 and
between 1985 and March 1990, surveillance was retrospec-
tive, largely relying on death certificates for case identifica-
tion. Between 1980 and 1984 and since 1990, surveillance has
been prospective: The majority of suspected cases have been
seen by members of the National Creutzfeldt-Jakob Disease
TABLE 2. Person-years of surveillance for Creutzfeldt-Jakob disease (estimated by linear interpolation
between censuses) and numbers of sporadic cases in England and Wales in 1970–1984 and in the entire
United Kingdom in 1985–1997, by age group and by period, 1970–1997*
30–39
40–49
50–59
60–69
≥70
Total
Age
group
(years)
Person-years of surveillance
(millions)
60,921
58,822
58,160
51,905
44,322
274,130
Cases of sporadic Creutzfeldt-Jakob disease
in England and Wales in 1970–1984 and
in the entire United Kingdom in 1985–1997
1970–1979 1980–1989 1990–1997
74,252
64,045
59,173
53,957
55,827
307,254
68,979
62,318
49,896
44,331
51,658
277,183
5
6
44
71
19
145
7
8
52
112
67
247
1970–1979 1980–1989 1990–1997
1
17
64
133
110
326
* Data were obtained from the National Creutzfeldt-Jakob Disease Surveillance Unit.
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FIGURE 1. Incidence of sporadic Creutzfeldt-Jakob disease per 50 million person-years during the periods 1970–1979, 1980–1989, and
1990–1997 (left side) and in birth cohorts C2 (1910) to C6 (1950) (right side). The upper portion of the figure shows data on the arithmetic scale;
the lower portion shows data on the logarithmic scale. Cohorts C1 (1900) and C7 (1960) are not represented because they corresponded to
one observation unit each.
Surveillance Unit, which continues to obtain death certifi-
cates. In this paper, the post-1990 numbers were not consid-
ered to be biased by underreporting, and an age-period model
was used to illustrate the assumption of a period effect due to
underascertainment before 1990. This model has estimated
low reporting rates (e.g., 0.66 in 1980–1989). Low reporting
rates were also found for BSE in the 1980s (11). This may be
a common feature of rare or new diseases, such as
Creutzfeldt-Jakob disease and BSE, respectively.
However, an increase in autopsies since 1979 was not
found likely to explain the increase in deaths certified as
being due to Creutzfeldt-Jakob disease (15). According to
the zoonotic hypothesis (16, 17), which is not supported by
any epidemiologic data so far, there may be other unknown
factors governing the rise in incidence. An age-cohort model
based on this assumption has led to a good fit. The incidence
trend was explained equally well by a time factor—such as
better ascertainment after a given time—or as a conse-
quence of variation between cohorts. The main point is that
a linear trend in the period terms can mimic a cohort factor
in an age-cohort model (18). From a statistical viewpoint, it
is impossible to designate unambiguously a linear trend in
rates as either a period trend or a cohort trend. This techni-
cal difficulty makes hazardous any interpretation of the data
which does not rely primarily on epidemiologic grounds.
Hence, the demonstration of an etiologic cohort factor can-
not be based on this sort of statistical analysis alone, which
is equally consistent with an interpretation of a time factor
of improvement in ascertainment (1) and with a hypothesis
relating the rise in incidence to some environmental factor
with different exposure levels among the different cohorts.
Nevertheless, in the event that such an unrecognized etio-
logic factor is involved, our models indicated that this factor
would cause an increase of less than 100 cases by 2020
(results not shown). This result is more optimistic than
Neilson’s predictions (19): Assuming an increased exposure
to an environmental risk factor, he stated that an “epidemic”
may result in a maximum of 4,000 cases over the next 20
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years. So far, the key hypothesis of a cohort factor does not
rely on any field data, and it might be challenged by current
studies. Only in that case, according to the precautionary
principle, would the age-cohort model represent an appro-
priate model. This work illustrates how interpreting sporadic
Creutzfeldt-Jakob disease data depends crucially on
TABLE 3. Goodness of fit achieved by fitting an age-period model* and an age-cohort model† to the
incidence of Creutzfeldt-Jakob disease in the United Kingdom, assessed by the deviance and the Akaike
Information Criterion (AIC), and estimated factors’ effects, 1970–1997
Age-period model (8 
parameters, 7 df)
Deviance = 13.05
(not significant)
AIC = 29.05
Model
30–39
40–49
50–59
60–69
≥70
Age
group
(years)
Age
effect
(eAi    /eA4)
95% CI‡
0.029
0.078
0.454
1.000§
0.669
0.017, 0.051
0.054, 0.112
0.376, 0.549
0.553, 0.810
1970–1979
1970–1979
1980–1989
1990–1997
Period
Reporting
effect
(ePj /eP3)
95% CI
* The age-period model relied on the two extreme assumptions (see “Discussion”); 1) there was no cohort
factor (no etiologic environmental factor of exposure involved in the incidence trend) and 2) past underreporting 
in a given period was of equal importance within the different age groups, except in 1970–1979 among people
aged ≥70 years (it was assumed to be different).
† The age-cohort model relied on the two extreme assumptions (see “Discussion”): 1) there was no period  
factor (no past reporting bias involved in the incidence trend) and 2) past variations in exposure to an unknown
etiologic factor were involved in the incidence trend.
‡ CI, confidence interval. The 95% confidence intervals were estimated by considering the risk relative to the
fourth age group (60–69 years), the third period (1990–1997), and the third cohort (1920), respectively. These  
levels corresponded to the highest number of cases and were used as a referent group.
§ Referent group.
Age-cohort model (11
parameters, 4 df)
Deviance = 1.93
(not significant)
AIC = 23.93
30–39
40–49
50–59
60–69
≥70
0.015
0.035
0.319
1.000§
0.949
0.007, 0.033
0.021, 0.060
0.254, 0.402
0.776, 1.161
C1 (1900)
C2 (1910)
C3 (1920)
C4 (1930)
C5 (1940)
C6 (1950)
C7 (1960)
0.206
0.601
1.000§
1.336
1.838
3.271
0.429
Cohort
Cohort
effect
(eCk /eC3)
95% CI
0.128, 0.334
0.488, 0.741
1.090, 1.639
1.327, 2.547
1.687, 6.340
0.052, 3.504
(cases aged ≥70 years)
0.214 0.103, 0.442
(cases aged <70 years)
0.496 0.410, 0.615
0.655 0.555, 0.773
1.000§
TABLE 4. Numbers of cases of sporadic Creutzfeldt-Jakob disease predicted by the age-period model and the age-cohort
model, United Kingdom, 1970–1997
Age
group
(years)
1970–1979
3
7
39
77
19
4
6
41
68
19
1980–1989
Prediction 95% CI* Obs*
1, 7
3, 14
23, 68
54, 110
7, 55
1, 13
3, 15
28, 60
48, 98
8, 44
5
6
44
71
19
5
6
44
71
19
4
10
53
106
73
8
9
55
118
70
2, 10
5, 19
32, 87
78, 144
45, 120
2, 39
3, 25
31, 100
102, 138
40, 123
Prediction
1990–1997
95% CI
7
8
52
112
67
7
8
52
112
67
* CI, confidence interval; Obs, observed number of cases.
Age-period model
30–39
40–49
50–59
60–69
≥70
Age-cohort model
30–39
40–49
50–59
60–69
≥70
Obs Prediction 95% CI Obs
6
14
68
133
103
1
16
64
130
108
3, 12
9, 24
49, 94
115, 153
74, 144
0, 20
4, 60
32, 131
91, 186
75, 153
1
17
64
133
110
1
17
64
133
110
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hypotheses which are still being debated among experts, and
encourages us to look further for possible causes of sporadic
Creutzfeldt-Jakob disease.
The results of our analyses correspond to the conclusions
of field epidemiologic surveys such as those of Wientjens
(20) and Will et al. (21):
Exposure to cows and sheep was associated with a border-
line significant increased risk of Creutzfeldt-Jakob disease
(OR 1.7, 95% CI 0.9 to 3.1 and OR 1.6, 95% CI 0.9 to 2.9,
respectively). Also, there was a nonsignificant increased risk
of Creutzfeldt-Jakob disease for subjects living in a rural
area at diagnosis (OR 1.4, 95% CI 0.8 to 2.4)… Our data
cannot exclude an environmental source of infection that
might have occurred early in childhood. The ongoing sys-
tematic surveillance of Creutzfeldt-Jakob disease in several
European countries might provide evidence for such expo-
sure as residential histories throughout life are studied.
These extensive studies with similar design will be highly
comparable and therefore will be able to resolve the prob-
lem of selection bias and of the limited statistical power of
our analysis (20, p. 1290).
The sharp decrease in mortality at older ages has been
described in other studies and is unexplained. Poor case
ascertainment in the elderly is a possible explanation,
though the clinical features of the disease are striking. An
alternative explanation is that Creutzfeldt-Jakob disease has
a limited incubation period, albeit measured in decades, and
that exposure to the agent early in life results in a maximal
age at which the disease is likely to become manifest. There
are few precedents for such a mechanism, however, as, in
general, if incubation periods are long they are also highly
variable (21, p. 753).
Further analyses should be carried out with new European
data—especially since the fourth annual report of the
National Creutzfeldt-Jakob Disease Surveillance Unit
showed that a rise in incidence has also been observed in
other countries (France, the United States, etc.) but an
excess of female cases has been observed only in the United
Kingdom (17).
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